Exenatide (exendin-4) studies: 530 papers with results
Page 2 of 11
- Combined exenatide and dapagliflozin has no additive effects on reduction of hepatocellular lipids despite better glycaemic control in patients with type 2 diabetes mellitus treated with metformin: EXENDA, a 24-week, prospective, randomized, placebo-controlled pilot trial.
Harreiter J · Diabetes, obesity & metabolism · 2021
Randomized controlled trial · 7 results
- Treatment of clozapine-associated obesity and diabetes with exenatide in adults with schizophrenia: A randomized controlled trial (CODEX).
Siskind DJ · Diabetes, obesity & metabolism · 2018
Randomized controlled trial · 6 results
- The effect of exenatide on lisinopril pharmacodynamics and pharmacokinetics in patients with hypertension.
Linnebjerg H · International journal of clinical pharmacology and therapeutics · 2009
Randomized controlled trial · 5 results
- Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety.
Nathanson D · Diabetologia · 2012
Randomized controlled trial · 8 results
- Prehospital exenatide in hyperglycemic stroke-A randomized trial.
Larsson M · Acta neurologica Scandinavica · 2019
Randomized controlled trial · 2 results
- The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial.
Mitchell JL · Brain : a journal of neurology · 2023
Randomized controlled trial · 4 results
- Effect of exenatide, sitagliptin, or glimepiride on β-cell secretory capacity in early type 2 diabetes.
Gudipaty L · Diabetes care · 2014
Randomized controlled trial · 4 results
- Pharmacology and tolerability of a single dose of exenatide in adolescent patients with type 2 diabetes mellitus being treated with metformin: a randomized, placebo-controlled, single-blind, dose-escalation, crossover study.
Malloy J · Clinical therapeutics · 2009
Randomized controlled trial · 11 results
- Exenatide as a weight-loss therapy in extreme pediatric obesity: a randomized, controlled pilot study.
Kelly AS · Obesity (Silver Spring, Md.) · 2012
Randomized controlled trial · 7 results
- Glucagon-like peptide-1 receptor agonist exenatide has no acute effect on MRI-measured exocrine pancreatic function in patients with type 2 diabetes: a randomized trial.
Smits MM · Diabetes, obesity & metabolism · 2016
Randomized controlled trial · 4 results
- Exenatide corrects postprandial hyperglycaemia in young people with cystic fibrosis and impaired glucose tolerance: A randomized crossover trial.
Geyer MC · Diabetes, obesity & metabolism · 2019
Randomized controlled trial · 7 results
- Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial.
Buse JB · Annals of internal medicine · 2011
Randomized controlled trial · 10 results
- Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome.
Elkind-Hirsch K · The Journal of clinical endocrinology and metabolism · 2008
Randomized controlled trial · 13 results
- The fate of taspoglutide, a weekly GLP-1 receptor agonist, versus twice-daily exenatide for type 2 diabetes: the T-emerge 2 trial.
Rosenstock J · Diabetes care · 2013
Randomized controlled trial · 15 results
- Comparison of the effects on glycaemic control and β-cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel-group trial (the CONFIDENCE study).
Xu W · Journal of internal medicine · 2015
Randomized controlled trial · 5 results
- Exenatide at therapeutic and supratherapeutic concentrations does not prolong the QTc interval in healthy subjects.
Darpö B · British journal of clinical pharmacology · 2013
Randomized controlled trial · 4 results
- Albuminuria-lowering effect of dapagliflozin, exenatide, and their combination in patients with type 2 diabetes: A randomized cross-over clinical study.
van der Aart-van der Beek AB · Diabetes, obesity & metabolism · 2023
Randomized controlled trial · 16 results
- Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trial.
Gatta-Cherifi B · European journal of endocrinology · 2024
Randomized controlled trial · 4 results
- Comparing the effects of twice-daily exenatide and insulin on renal function in patients with type 2 diabetes mellitus: secondary analysis of a randomized controlled trial.
Zhang J · Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2022
Randomized controlled trial · 5 results
- Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes Mellitus With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial.
Fudim M · Circulation · 2019
Randomized controlled trial · 7 results
- Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).
Reed SD · Diabetes care · 2020
Randomized controlled trial · 9 results
- Effect of short-acting exenatide administered three times daily on markers of cardiovascular disease in type 1 diabetes: A randomized double-blind placebo-controlled trial.
Johansen NJ · Diabetes, obesity & metabolism · 2020
Randomized controlled trial · 10 results
- Exenatide Adjunct to Nicotine Patch Facilitates Smoking Cessation and May Reduce Post-Cessation Weight Gain: A Pilot Randomized Controlled Trial.
Yammine L · Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
Randomized controlled trial · 5 results
- Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial.
van Ruiten CC · Diabetes, obesity & metabolism · 2021
Randomized controlled trial · 6 results
- Mechanisms underlying the blood pressure lowering effects of dapagliflozin, exenatide, and their combination in people with type 2 diabetes: a secondary analysis of a randomized trial.
van Ruiten CC · Cardiovascular diabetology · 2022
Randomized controlled trial · 7 results
- A double-blind, placebo-controlled trial of exenatide for the treatment of olanzapine-related weight gain in obese and overweight adults.
Patino LR · Journal of affective disorders · 2025
Randomized controlled trial · 5 results
- Effects of exenatide versus insulin analogues on weight change in subjects with type 2 diabetes: a pooled post-hoc analysis.
Glass LC · Current medical research and opinion · 2008
Randomized controlled trial · 5 results
- Exenatide once weekly decreases urinary albumin excretion in patients with type 2 diabetes and elevated albuminuria: Pooled analysis of randomized active controlled clinical trials.
van der Aart-van der Beek AB · Diabetes, obesity & metabolism · 2020
Randomized controlled trial · 9 results
- Exenatide twice daily versus insulin glargine for the treatment of type 2 diabetes in Poland - subgroup data from a randomised multinational trial GWAA.
Matyjaszek-Matuszek B · Endokrynologia Polska · 2013
Randomized controlled trial · 12 results
- What Effects Might Exenatide have on Non-Motor Symptoms in Parkinson's Disease: A Post Hoc Analysis.
Athauda D · Journal of Parkinson's disease · 2018
Randomized controlled trial · 5 results
- Efficacy and Safety Over 2 Years of Exenatide Plus Dapagliflozin in the DURATION-8 Study: A Multicenter, Double-Blind, Phase 3, Randomized Controlled Trial.
Jabbour SA · Diabetes care · 2020
Randomized controlled trial · 5 results
- Brain Activation in Response to Low-Calorie Food Pictures: An Explorative Analysis of a Randomized Trial With Dapagliflozin and Exenatide.
van Ruiten CC · Frontiers in endocrinology · 2022
Randomized controlled trial · 5 results
- Risk factors for bone fractures in type 2 diabetes and the impact of once-weekly exenatide: insights from an EXSCEL post-hoc analysis.
Maddaloni E · Diabetes research and clinical practice · 2025
Randomized controlled trial · 1 result
- Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).
Davis TME · Cardiovascular diabetology · 2022
Randomized controlled trial · 7 results
- Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study.
Simó R · Cardiovascular diabetology · 2015
Randomized controlled trial · 12 results
- Efficacy and tolerability of exenatide once weekly versus sitagliptin in patients with type 2 diabetes mellitus: a retrospective analysis of pooled clinical trial data.
Malloy J · Postgraduate medicine · 2013
Randomized controlled trial · 8 results
- Efficacy and safety of exenatide once-weekly vs exenatide twice-daily in Asian patients with type 2 diabetes mellitus.
Ji L · Journal of diabetes investigation · 2013
Randomized controlled trial · 14 results
- Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.
Heine RJ · Annals of internal medicine · 2005
Randomized controlled trial · 11 results
- A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study.
Nauck MA · Diabetologia · 2007
Randomized controlled trial · 9 results
- Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes.
Secnik Boye K · Health and quality of life outcomes · 2006
Randomized controlled trial · 2 results
- Safety and efficacy of once-weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes over 84 weeks.
Diamant M · Diabetes care · 2012
Randomized controlled trial · 8 results
- Patient-reported outcomes are superior in patients with Type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label study.
Schmidt WE · Diabetic medicine : a journal of the British Diabetic Association · 2011
Randomized controlled trial · 18 results
- Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes.
Buse JB · Diabetes care · 2004
Randomized controlled trial · 8 results
- Exenatide twice daily versus premixed insulin aspart 70/30 in metformin-treated patients with type 2 diabetes: a randomized 26-week study on glycemic control and hypoglycemia.
Gallwitz B · Diabetes care · 2011
Randomized controlled trial · 4 results
- Exenatide effects on statin pharmacokinetics and lipid response.
Kothare PA · International journal of clinical pharmacology and therapeutics · 2007
Randomized controlled trial · 8 results
- Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily.
Best JH · Diabetic medicine : a journal of the British Diabetic Association · 2009
Randomized controlled trial · 10 results
- Exenatide once weekly versus daily basal insulin as add-on treatment to metformin with or without a sulfonylurea: a retrospective pooled analysis in patients with poor glycemic control.
Grimm M · Postgraduate medicine · 2013
Randomized controlled trial · 5 results
- DURATION-1: exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks.
Buse JB · Diabetes care · 2010
Randomized controlled trial · 8 results
- Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study.
Russell-Jones D · Diabetes care · 2012
Randomized controlled trial · 10 results
- Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study.
Davies MJ · Diabetes, obesity & metabolism · 2009
Randomized controlled trial · 7 results